Aparasu RR - Search Results

1

Prescribing of disease modifying agents in older adults with multiple sclerosis.

Talwar A, Earla JR, Hutton GJ, Aparasu RR. Talwar A, et al. Among authors: aparasu rr. Mult Scler Relat Disord. 2022 Jan;57:103308. doi: 10.1016/j.msard.2021.103308. Epub 2021 Oct 5. Mult Scler Relat Disord. 2022. PMID: 35158421

2

Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.

Chatterjee S, Chen H, Johnson ML, Aparasu RR. Chatterjee S, et al. Among authors: aparasu rr. Drugs Aging. 2012 Oct;29(10):807-17. doi: 10.1007/s40266-012-0013-4. Drugs Aging. 2012. PMID: 23018582

3

Potentially inappropriate anticholinergic medication use in older adults with dementia.

Kachru N, Carnahan RM, Johnson ML, Aparasu RR. Kachru N, et al. Among authors: aparasu rr. J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):603-612. doi: 10.1331/JAPhA.2015.14288. J Am Pharm Assoc (2003). 2015. PMID: 26501745

4

Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study.

Kachru N, Holmes HM, Johnson ML, Chen H, Aparasu RR. Kachru N, et al. Among authors: aparasu rr. J Gen Intern Med. 2020 Jul;35(7):2084-2093. doi: 10.1007/s11606-020-05634-3. Epub 2020 Feb 5. J Gen Intern Med. 2020. PMID: 32026255 Free PMC article.

5

Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease.

Chekani F, Holmes HM, Johnson ML, Chen H, Sherer JT, Aparasu RR. Chekani F, et al. Among authors: aparasu rr. Am J Geriatr Psychiatry. 2020 Oct;28(10):1079-1088. doi: 10.1016/j.jagp.2020.01.193. Epub 2020 Feb 7. Am J Geriatr Psychiatry. 2020. PMID: 32147383

6

Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data.

Earla JR, Paranjpe R, Kachru N, Hutton GJ, Aparasu RR. Earla JR, et al. Among authors: aparasu rr. Res Social Adm Pharm. 2020 Dec;16(12):1670-1676. doi: 10.1016/j.sapharm.2020.02.016. Epub 2020 Mar 11. Res Social Adm Pharm. 2020. PMID: 32171597

7

Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015.

Earla JR, Thornton JD, Hutton GJ, Aparasu RR. Earla JR, et al. Among authors: aparasu rr. J Manag Care Spec Pharm. 2020 Jun;26(6):741-749. doi: 10.18553/jmcp.2020.26.6.741. J Manag Care Spec Pharm. 2020. PMID: 32463779 Free PMC article.

8

Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records.

Earla JR, Hutton GJ, Thornton JD, Aparasu RR. Earla JR, et al. Among authors: aparasu rr. Mult Scler Relat Disord. 2020 Oct;45:102334. doi: 10.1016/j.msard.2020.102334. Epub 2020 Jun 24. Mult Scler Relat Disord. 2020. PMID: 32629400

9

Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries.

Aparasu RR, Sura S, Earla JR, Shiozawa A, Ng DB, Schermer CR. Aparasu RR, et al. Adv Ther. 2020 Aug;37(8):3584-3605. doi: 10.1007/s12325-020-01412-z. Epub 2020 Jul 7. Adv Ther. 2020. PMID: 32638205 Free PMC article.

10

Anticholinergic medications and risk of dementia in older adults: Where are we now?

Chatterjee S, Talwar A, Aparasu RR. Chatterjee S, et al. Among authors: aparasu rr. Expert Opin Drug Saf. 2020 Oct;19(10):1251-1267. doi: 10.1080/14740338.2020.1811227. Epub 2020 Aug 31. Expert Opin Drug Saf. 2020. PMID: 32797761 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters